Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/23068
Title: | Therapeutic strategies for multiple sclerosis: Current data | Authors: | Georgiou, Anastasios M. | Major Field of Science: | Medical and Health Sciences | Field Category: | Clinical Medicine | Keywords: | Disease‑modifying therapies;Multiple sclerosis;Neuroprotective strategies | Issue Date: | Mar-2015 | Source: | International Journal of Health & Allied Sciences, vol. 4, no, 1, pp. 3-8 | Volume: | 4 | Issue: | 1 | Start page: | 3 | End page: | 8 | Journal: | International Journal of Health & Allied Sciences | Abstract: | At present, the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved drugs for Relapsing Remitting Multiple Sclerosis (RRMS) and Secondary Progressive MS (SPMS). In this paper, modern therapeutic strategies for MS are reviewed. A comprehensive research in MEDLINE, PUBMED, and SCIENCEDIRECT databases using two Boolean phrases {i.e. 1. [(Multiple Sclerosis) and (Disease Modifying Therapies)] and 2. [(Multiple Sclerosis) and (Neuroprotective Therapies)]} yielded more than 1,5000 articles in total. Therefore, for the purposes of this paper, articles written within the last decade were considered for review. | URI: | https://hdl.handle.net/20.500.14279/23068 | ISSN: | 2278344X | DOI: | 10.4103/2278-344X.149199 | Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International | Type: | Article | Affiliation : | James Cook University | Publication Type: | Peer Reviewed |
Appears in Collections: | Άρθρα/Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IntJHealthAlliedSci413-1951091_052510.pdf | Fulltext | 558.31 kB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
274
Last Week
1
1
Last month
4
4
checked on Nov 13, 2024
Download(s)
194
checked on Nov 13, 2024
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License